The HUAWEI Sence G1 is the company's first continuous glucose monitor (CGM). It has just launched in China with a Class III medical device license.
- HUAWEI has unveiled the HUAWEI Sence G1, its first continuous glucose monitor (CGM), announced in China.
- It is also HUAWEI's first Class III medical device. According to VCBeat, China's NMPA approved it on October 30.
- The monitor connects to HUAWEI phones, smartwatches, and bands, and sends alerts when blood glucose rises or drops abnormally.
- Pricing, release date, and sensor lifespan have not been announced, and a global launch is unconfirmed.
Table of Contents
HUAWEI expands into glucose monitoring
After smartwatches and bands with blood pressure measurement, HUAWEI is pushing its wearable health lineup further with the HUAWEI Sence G1. It is the company's first continuous glucose monitor (CGM), introduced in a post on Weibo.
The device works within the HUAWEI ecosystem. Users can view their glucose readings on a HUAWEI phone, smartwatch, or band. It also sends alerts when blood glucose spikes or falls abnormally.
Specs and what's still missing
Judging by the images, the sensor is about the size of a US quarter and is designed to be worn on the back of the upper arm. HUAWEI has not said anything about pricing, release date, or how long a sensor can be worn before it needs replacing.
According to leaks cited by IT Home, the monitor's lag time is between 5 and 15 minutes, with a MARD error below 10%. This is unofficial information and awaits confirmation from HUAWEI.
Three years of development and a medical license
HUAWEI vice president Bruce Lee said this was one of the products that took the longest to get right. According to him, the team first tested it in December 2023, and the engineers on the project had worn it for even longer.
The long development cycle may stem from medical certification requirements. According to VCBeat, China's National Medical Products Administration (NMPA) approved the device on October 30. The HUAWEI Sence G1 is also the company's first Class III medical device.
The HUAWEI Sence G1 points to a notable direction for wearables: moving from heart rate and blood pressure to metrics that require stricter medical licensing. However, the monitor depends on other HUAWEI products, so whether it will reach international markets remains open. Readers in Vietnam should wait for pricing, sensor lifespan, and independently verified data before getting their hopes up.
Source: Android Authority
Reviewed by: Hero Association
